We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 7,420

Brazil patent examination: Defying the backlog
  • DANIEL Legal & IP Strategy
  • Brazil
  • December 19 2018

Despite a reputation for being slow to grant patents, Brazil’s IP office has introduced a number of programmes to expedite examinationwith some


Timing
  • Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • USA
  • December 18 2018

Our timing statistics track time to the posting of a PTAB Final Written Decision on the merits. These statistics do not include requests for adverse


Trade Show Publication Dooms Patent in IPR Appeal Despite Contrary Decision in ITC Appeal
  • Marshall Gerstein & Borun LLP
  • USA
  • December 17 2018

Inter partes review not only provides a faster and cheaper way to challenge patent validity, but also expands the Patent Office’s ability to develop


Window into the Past
  • Harness, Dickey & Pierce, PLC
  • USA
  • December 14 2018

Patents can be an interesting window into the past. On December 14, 1937, for example, U.S. Patent No. D107425 issued to Wallace K. Harrison and J


DOJ to Withdraw Assent to Standards-Essential Patent Policy Statement
  • Latham & Watkins LLP
  • USA
  • December 14 2018

Assistant Attorney General Makan Derahim has announced that the Department of Justice’s (DOJ’s) Antitrust Division will withdraw its assent to the


Motion to Amend Denied for Failure to Meet 42.121 Requirements
  • Jones Day
  • USA
  • December 13 2018

On November 26, 2018, the PTAB entered its Final Written Decision in Intel Corp. v. Alacritech, Inc., Case IPR2017-01391, denying Patent Owner


Federal Circuit Holds 156 Patent Term Extension Not Invalid for Obviousness-Type Double Patenting
  • Venable LLP
  • USA
  • December 13 2018

On December 7, 2018, a Federal Circuit panel (Moore, Chen, and Hughes) in Novartis AG v. Ezra Ventures LLC, No. 2017-2284, held that a patent term


Click-to-Call Cert Petition - Second Extension of Time Granted
  • Jones Day
  • USA
  • December 12 2018

As reported in a prior post, DexMedia, Inc. previously filed an Application for Extension of Time to File a Petition for a Writ of Certiorari


Recent Federal Circuit Decisions on Obviousness-Type Double Patenting May Shape Life Science Patent Portfolio Management
  • Dechert LLP
  • USA
  • December 12 2018

The Federal Circuit recently decided two appeals, Novartis AG v. Ezra Ventures LLC ("Ezra") and Novartis Pharms. Corp. v. Breckenridge Pharm. Inc.


2019 to Bring Clarity to 101 Disputes
  • Ropes & Gray LLP
  • USA
  • December 11 2018

As we close out 2018, there may be some hope on the horizon for those confounded by the current state of patent eligibility determinations under 35 U